Analysts Issue Forecasts for Kinaxis’ Q3 Earnings (TSE:KXS)

Kinaxis Inc. (TSE:KXSFree Report) – Stock analysts at Stifel Canada upped their Q3 2024 earnings per share estimates for shares of Kinaxis in a research note issued on Wednesday, October 23rd. Stifel Canada analyst S. Sukumar now forecasts that the company will post earnings of $0.43 per share for the quarter, up from their previous estimate of $0.41. The consensus estimate for Kinaxis’ current full-year earnings is $4.25 per share. Stifel Canada also issued estimates for Kinaxis’ Q4 2024 earnings at $0.54 EPS and FY2024 earnings at $1.78 EPS.

Kinaxis (TSE:KXSGet Free Report) last released its quarterly earnings results on Wednesday, July 31st. The company reported C$0.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of C$0.27 by C$0.15. The business had revenue of C$161.83 million for the quarter, compared to analyst estimates of C$160.55 million. Kinaxis had a net margin of 4.59% and a return on equity of 4.87%.

Several other analysts have also recently commented on KXS. Scotiabank decreased their target price on Kinaxis from C$200.00 to C$190.00 in a research report on Thursday, August 29th. ATB Capital reduced their price objective on Kinaxis from C$215.00 to C$205.00 and set an “outperform” rating for the company in a research note on Friday, August 2nd. Stifel Nicolaus lowered their target price on Kinaxis from C$210.00 to C$195.00 and set a “buy” rating on the stock in a research note on Friday, August 2nd. Finally, TD Securities reduced their price target on shares of Kinaxis from C$200.00 to C$195.00 in a research report on Friday, August 2nd. One analyst has rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat, Kinaxis presently has a consensus rating of “Moderate Buy” and an average target price of C$192.11.

View Our Latest Research Report on KXS

Kinaxis Trading Down 1.4 %

TSE KXS opened at C$157.05 on Friday. The firm’s 50 day moving average price is C$154.74 and its two-hundred day moving average price is C$154.08. The company has a debt-to-equity ratio of 12.40, a quick ratio of 2.29 and a current ratio of 1.90. Kinaxis has a twelve month low of C$129.13 and a twelve month high of C$172.83. The stock has a market cap of C$4.44 billion, a price-to-earnings ratio of 157.05, a PEG ratio of 3.60 and a beta of 0.78.

Insider Activity

In related news, Senior Officer Andrew William Robert Bell sold 701 shares of the stock in a transaction that occurred on Wednesday, August 14th. The stock was sold at an average price of C$149.56, for a total value of C$104,841.70. Following the transaction, the insider now owns 831 shares in the company, valued at approximately C$124,284.53. This represents a 0.00 % decrease in their ownership of the stock. In related news, Director Angel Luis Mendez bought 1,400 shares of the business’s stock in a transaction on Friday, September 6th. The shares were bought at an average cost of C$148.96 per share, for a total transaction of C$208,537.00. Also, Senior Officer Andrew William Robert Bell sold 701 shares of the business’s stock in a transaction dated Wednesday, August 14th. The stock was sold at an average price of C$149.56, for a total value of C$104,841.70. Following the completion of the sale, the insider now directly owns 831 shares of the company’s stock, valued at C$124,284.53. This represents a 0.00 % decrease in their position. Insiders sold a total of 8,265 shares of company stock worth $1,268,146 in the last three months. 1.20% of the stock is owned by insiders.

Kinaxis Company Profile

(Get Free Report)

Kinaxis Inc provides cloud-based subscription software for supply chain operations in the United States, Europe, Asia, and Canada. It offers RapidResponse, a cloud-based platform, which provides advanced planning, sales and operation planning, supply and demand planning, inventory management, and command and control center services.

Recommended Stories

Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.